Barbara Klencke's Net Worth
$611 Thousand
Who is Barbara Klencke?
Barbara Klencke does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Sierra Oncology, Inc., eFFECTOR Therapeutics, Inc., TScan Therapeutics, Inc., and Xencor Inc.
SEC CIK
Barbara Klencke's CIK is 0001647647
Past Insider Trading and Trends
2023 was Barbara Klencke's most active year for acquiring shares with 5 total transactions. Barbara Klencke's most active month to acquire stocks was the month of February. 2022 was Barbara Klencke's most active year for disposing of shares, totalling 12 transactions. Barbara Klencke's most active month to dispose stocks was the month of June. 2020 saw Barbara Klencke paying a total of $113,447.17 for 176,366 shares, this is the most they've acquired in one year. In 2022 Barbara Klencke cashed out on 347,551 shares for a total of $825,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sierra Oncology, Inc. No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -15.00K |
$55.00 | -$825,000.00 |
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
| +162.01% | 9.28K |
$12.24 | $113,447.17 | 15K |
Aug 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
∞
| 229K |
$0.44 | $100,638.30 | 229K |
Aug 22 - Aug 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
eFFECTOR Therapeutics, Inc. (EFTR) Snapshot price: $10.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
TScan Therapeutics, Inc. (TCRX) Snapshot price: $5.85
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +20.00% | 5K |
$5.08 | $25,400.00 | 30K |
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Xencor Inc (XNCR) Snapshot price: $18.77
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |